Showing results (331-340 of 385) with videos related to

Sort By:
Pageof 39
Neurology|January 23, 2025
Conventional MRI-Based Structural Disconnection and Morphometric Similarity Networks and Their Clinical Correlates in Multiple SclerosisMario Tranfa, Maria Petracca, Marcello Moccia, et al.
Diagnostics (Basel, Switzerland)|August 27, 2021
Walk Your Talk: Real-World Adherence to Guidelines on the Use of MRI in Multiple SclerosisMario Tortora, Mario Tranfa, Anna Chiara D'Elia, et al.
European Radiology|February 27, 2020
2D linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosisGiuseppe Pontillo, Sirio Cocozza, Martina Di Stasi, et al.
European Journal of Neurology|September 10, 2022
Signs and symptoms of COVID-19 in patients with multiple sclerosisIrene Schiavetti, Luca Carmisciano, Marta Ponzano, et al.
Multiple Sclerosis and Related Disorders|February 5, 2026
First demyelinating attack in children: A twelve year single center cohortAlessandro Santagostino Barbone, Thea Giacomini, Silvia Casabona, et al.
International Journal of Medical Informatics|June 10, 2026
Web-based family-reported outcomes to assess family functioning in multiple sclerosis: an Italian multicenter digital surveyLuigi Lavorgna, Giuseppina Miele, Marta Ponzano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 19, 2025
Age-dependent response to initial highly effective treatment in relapsing multiple sclerosisEmilio Portaccio, Matteo Betti, Ermelinda De Meo, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 10, 2021
COVID-19 Severity in Multiple Sclerosis: Putting Data Into ContextMaria Pia Sormani, Irene Schiavetti, Luca Carmisciano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 10, 2026
Task-oriented virtual reality and brain functional plasticity in progressive multiple sclerosis: A randomized controlled trial on upper limb rehabilitationMehrnaz Hamedani, Giada Lombardi, Giacomo Boffa, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2022
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patientsGisella Guerrera, Alessandra Mandelli, Annamaria Finardi, et al.
Pageof 39